L'obésité augmente la susceptibilité aux troubles anxieux et de l’humeur et, à son tour, un affect négatif influence les comportements alimentaires. Faisant partie du circuit de la récompense, le noyau accumbens intègre la signalisation dopaminergique avec des signaux corticaux et traduit ces informations en comportements motivés. Chez le rongeur, une alimentation riche en gras favorise des adaptations dopaminergiques au noyau accumbens et des études d'imagerie révèlent un recrutement amoindri de cette région du cerveau lors de la consommation d’aliments palatables en obésité humaine. Les altérations dopaminergiques au noyau accumbens perturbent les fonctions de récompense et contribuent fortement aux déficits motivationnels couramment observés en dépression. L'obésité induite par la diète résulte d'une surconsommation chronique d'aliments à forte densité énergétique, tels que ceux riches en gras, mais des acides gras alimentaires distincts influencent différemment la santé métabolique et l'humeur. Alors que les acides gras monoinsaturés, prédominants dans le régime méditerranéen, améliorent les paramètres du syndrome métabolique, les acides gras saturés, enrichis en produits d'origine animale et en aliments transformés, ont des actions pro-inflammatoires et leur consommation est corrélée aux symptômes dépressifs chez l’humain. Ainsi, nous avons émis l'hypothèse que l'obésité induite par une diète riche en gras saturés, et non monoinsaturés, favorise l’expression de comportements anxieux et dépressifs chez la souris via des adaptations moléculaires au noyau accumbens. Afin de tester cette hypothèse, nous avons exposé des souris mâles et femelles à une diète riche en gras saturés ou monoinsaturés ou à une diète faible en gras et avons évalué le rôle de l'inflammation au noyau accumbens dans l'expression d'un phénotype anxiodépressif. Dans notre première étude, impliquant uniquement des souris mâles, nous avons constaté que, malgré une prise de poids et une adiposité similaires, seules les souris nourries avec une diète riche en gras saturés présentaient des altérations métaboliques et des comportements anxiodépressifs. De plus, ces effets étaient accompagnés d'une augmentation des niveaux de marqueurs inflammatoires dans le noyau accumbens et, par approche virale, l’inhibition spécifique de la voie pro-inflammatoire du facteur nucléaire kappa-b dans cette région était suffisante pour empêcher l'expression de comportements anxiodépressifs ainsi que de recherche compulsive de sucrose. Dans notre deuxième étude, des souris femelles ont été placées sur les mêmes 3 régimes et nous avons également observé un phénotype anxiodépressif spécifique à la diète riche en gras saturés. Contrairement aux mâles, l'inflammation n'était pas associée à l’expression de comportements anxiodépressifs. À la place, des niveaux d'œstrogènes circulants élevés et une expression diminuée du récepteur à l’estrogène bêta dans le noyau accumbens ont distingué les souris sous diète riche en gras saturés des autres. Dans notre troisième étude, nous avons induit l'obésité et des comportements anxiodépressifs chez des souris mâles en les exposant à la diète riche en gras saturés. Par une approche chimiogénétique, nous avons renversé le phénotype dépressif induit par la diète riche en gras saturés en activant les neurones du noyau accumbens exprimant le récepteur dopaminergique de type 1. De plus, nous avons mis en évidence des effets différentiels de ces neurones, en condition de diète riche en gras saturés, avec une hausse des comportements anxieux par cette même manipulation. Dans notre quatrième étude, nous évaluons le potentiel d'un nouveau co-agoniste glucagon-like peptide-1/dexaméthasone à réduire la motivation pour les aliments riches en gras et en sucre chez les souris mâles. Nous avons constaté que ce co-agoniste pouvait inhiber, de manière aiguë, la motivation à obtenir des récompenses alimentaires à la fois sous diète contrôle et suite au sevrage d’une diète riche en gras et en sucre. Le traitement prolongé avec ce composé chez des souris obèses a permis de réduire le poids corporel et l'apport alimentaire, sans favoriser de comportements anxiodépressifs ou de déficit cognitif. Dans l'ensemble, notre travail supporte le rôle du noyau accumbens dans la susceptibilité accrue à l'anxiété et à la dépression chez les personnes obèses. Nous démontrons que la composition du régime alimentaire en différents acides gras, et non seulement la teneur, influence les altérations métaboliques et de l'humeur en obésité. Nos données suggèrent que cette relation est gouvernée par des mécanismes moléculaires distincts en fonction du sexe. Enfin, ces études pourraient orienter le développement de nouvelles approches thérapeutiques traitant à la fois les composantes métaboliques et motivationnelles de l'obésité. / Obesity increases the odds for mood disorders such as depression and anxiety and, in turn, negative affect influences feeding behaviours. Part of the reward circuitry, the nucleus accumbens integrates dopaminergic signaling with cortical inputs and translates this information into goal-oriented behaviours. In rodents, high-fat feeding promotes dopaminergic adaptations in the nucleus accumbens and imaging studies reveal blunted recruitment of this brain region during palatable food consumption in human obesity. Alterations in nucleus accumbens dopamine signaling disrupt reward function and heavily contribute to the motivational deficits commonly observed in depression. Diet-induced obesity results from chronic overconsumption of energy-dense foods, such as those with a high fat content, yet distinct dietary fatty acids influence metabolic health and mood differently. While monounsaturated fatty acids, predominant in the Mediterranean diet, have overall benefits for features of the metabolic syndrome, saturated fatty acids, enriched in animal-derived products and processed foods, have pro-inflammatory actions and their consumption correlates with depressive symptoms. Thus, we hypothesized that obesity induced by a saturated, but not monounsaturated, high-fat diet promotes anxiety and depressive behaviours in mice via molecular adaptations in the nucleus accumbens. In order to test this hypothesis, we placed male and female mice on either a saturated or monounsaturated high-fat diet or a control low-fat diet and assessed the role of nucleus accumbens inflammation in mediating the expression of an anxiodepressive phenotype. In our first study, only involving male mice, we found that, despite similar weight gain and overall adiposity, only mice fed the saturated high-fat diet displayed metabolic impairments and anxiodepressive behaviours. In addition, these impairments were accompanied by enhanced levels of inflammatory markers in the nucleus accumbens and region-specific viral mediated inhibition of the pro-inflammatory nuclear factor kappa-b pathway was sufficient to prevent the expression of anxiodepressive behaviours as well as compulsive sucrose-seeking. In our second study, female mice were placed on the same 3 diets and we also observed an anxiodepressive phenotype specific to the saturated high-fat diet. In contrast to the males, inflammation was not associated to the increase in anxiodepressive behaviours. Instead, elevated circulating levels of estrogen and diminished expression of estrogen receptor beta in the nucleus accumbens distinguished mice on the saturated high-fat diet from the others. In our third study, we induced obesity and anxiodepressive behaviours in male mice by exposing them to the saturated high-fat diet. Via a chemogenetic approach, we blocked the depressive phenotype induced by saturated high-fat feeding by activating neurons of the nucleus accumbens expressing the type 1 dopamine receptor. In addition, we evidenced differential effects of these neurons, under conditions of saturated high-fat feeding, as anxiety behaviours were enhanced by this same manipulation. In our fourth study, we assess the potential of a novel glucagon-like peptide-1/dexamethasone co-agonist to reduce motivation for high-fat/high-sugar rewards in male mice. We found that this co-agonist could acutely inhibit operant response for palatable foods under both chow and withdrawal from high-fat/high-sucrose diet conditions. Prolonged treatment with this compound in diet-induced obese mice successfully reduced body weight and food intake, without promoting anxiodepressive behaviours as well as cognitive impairment. Overall, our work supports a role for the nucleus accumbens in the greater susceptibility to anxiety and depression in obese individuals. We demonstrate that diet composition in fatty acids, and not just fat content, influences metabolic and mood impairments in obesity. Our data suggests this relationship to be mediating by distinct molecular mechanisms in a sex-specific manner. Finally, these studies may orient the development of novel therapeutic approaches addressing both the metabolic and motivational components of obesity.

The amphetamine derivative, 3,4-methylenedioxymethamphetamine (MDMA), is a popular drug often taken by young adults at dance clubs or rave parties. Laser light shows, fast-paced electronic music, and hot crowded dance floors are characteristic of these events, and Ecstasy users report that the acute effects of the drug are potentiated by these stimulatory conditions. However, it remains largely unknown how environmental stimuli impact the neurochemical and physiological effects of MDMA. The aim of the first study presented in this dissertation was to investigate how auditory stimuli (music, white noise, and no additional sound) influence MDMA conditioned place preference (CPP), self-administration, and nucleus accumbens (NAcc) dopamine (DA) and serotonin (5-HT) responses. Findings revealed a significant CPP for animals exposed to white noise during MDMA conditioning trials. After self-administration of MDMA (1.5 mg/kg), NAcc DA and 5-HT were highest in rats exposed to music during the test session. The second study aimed to investigate the effects of ambient temperature (23°or 32°C) on long-term MDMA self-administration and neurochemical responses. Results indicated no difference in self-administration or locomotor activity rates for the high versus room temperature groups across sessions. However, MDMA (3.0 mg/kg) administered in high ambient temperature resulted in significantly greater NAcc serotonin release compared to when taken at room temperature, but no differences in dopamine response was determined between the two conditions. Overall, these results indicate that auditory and thermal stimuli can effect MDMA-induced behavioral and neurochemical responses. The last aim tested a novel apparatus and method for use in animal models of drug reinforcement. By combining traditional CPP and self-administration procedures, this approach provided more informative data and circumvented some inherent drawbacks of each method alone. In addition to confirming the ability to produce drug conditioned place preferences after short- and long-term experiments, the long-term version of the procedure revealed a significant positive relationship between lever response rate and CPP magnitude. Therefore, this experimental design can be used to identify subgroups of rats that may vary in sensitivity to drug motivational effects. Further study of these populations may be useful in the development of behavioral and pharmacological therapies for drug addiction. / text

Die Glutamat-vermittelte Exzitotoxizität gilt als einer der wichtigsten neuropathologischen Faktoren der HIV-Demenz: Während Glutamat in physiologischer Konzentration als exzitatorischer Neurotransmitter fungiert, wirkt es in zu hoher Konzentration neurotoxisch. In vorliegender Arbeit wurde mittels Western Blotting die Proteinexpression der exzitatorischen Aminosäuretransporter EAAT1 und EAAT2 gemessen, die vor allem für den Abtransport von Glutamat aus dem synaptischen Spalt sorgen. Hierzu wurden Gehirne von mit dem simianen Immundefizienz Virus (SIV) infizierten chinesischen und indischen Rhesusaffen verwendet. SIV verursacht im SIV-Rhesusaffenmodell ähnliche Schäden wie das humane Immundefizienz Virus (HIV) beim Menschen. Zur Entstehung der SIV-Enzephalitis tragen, wie auch bei der HIV-Demenz, aktivierte Monozyten und Mikroglia bei, die u.a. das Neurotoxin Tumornekrosefaktor-alpha (TNF-alpha) sezernieren. Dessen Protein- und Genexpression wurde mittels ELISA und Real-Time-PCR ausgewertet. Für die vorliegende Arbeit wurden zwei für die HIV-Demenz besonders relevante Gehirnregionen ausgewählt: das Putamen, das als Teil der Basalganglien für die extrapyramidale Steuerung der Motorik zuständig ist, und der Nucleus Accumbens, der affektives und motivationales Verhalten in Bewegungsabläufe integriert. Als potentielle Pharmaka wurden der MAO-B-Hemmer Selegilin, der NMDAR-Antagonist Memantin sowie die Antioxidantien N-Acetylcystein (NAC) und Melatonin getestet. Es gelang in vorliegender Arbeit erstmals, eine Störung der Proteinexpression der glutamatergen Transporter EAAT1 und EAAT2 im Putamen mit zunehmender Dauer der SIV-Infektion und ihren dramatischen Verlust bei Entwicklung von AIDS nachzuweisen. Im Nucleus Accumbens fand sich eine relativ konstante Proteinexpression des EAAT1 und EAAT2 im Verlauf der SIV-Infektion. Weiterhin konnte ein Anstieg des TNF-alpha mit fortschreitender Infektionsdauer hinsichtlich der Genexpression im Putamen und der Proteinexpression im Nucleus Accumbens nachgewiesen werden. Die fehlende Eignung von Selegilin als neuroprotektive Substanz im Rahmen der SIV-Enzephalitis wurde repliziert. Memantin, NAC und Melatonin hingegen verbesserten in weiten Teilen die Expression von EAAT1 und EAAT2 und wirkten immunstimulierend, was sie zu interessanten Kandidaten für eine neuroprotektive Medikation macht. In beiden Hirnregionen zeigte sich bei den indischen Rhesusaffen eine höhere TNF-alpha-Expression als bei den chinesischen Tieren. Dies entspricht der Beobachtung, dass die SIV-Infektion bei indischen Rhesusaffen meist schneller und schwerer verläuft. / Glutamate-mediated excitotoxicity is considered one of the major neuropathological factors inducing HIV dementia: serving as an excitatory neurotransmitter in physiological concentration, glutamate exerts neurotoxic effects if secreted excessively. In the present study, the protein expression level of the excitatory amino acid transporters EAAT1 and EAAT2, which are responsible for the removal of glutamate from the synaptic cleft, was analyzed via Western Blotting. For this purpose, brains of Chinese and Indian macaques infected with the simian immunodeficiency virus (SIV) were used. SIV causes similar symptoms in the SIV/macaque model as the human immunodeficiency virus (HIV) does in humans. Similar to HIV-dementia, the development of SIV-encephalitis is triggered by activated monocytes and microglia, which secrete – among other things - the neurotoxin tumor necrosis factor-alpha (TNF-alpha). TNF-alpha protein and gene expression was examined using ELISA and real-time-PCR. For the present study, two brain regions were chosen due to their specific relevance for HIV-dementia: first the putamen, which is part of the basal ganglia and exerts influence on extrapyramidal motion sequences, and second the nucleus accumbens, which integrates affective and motivational behavior in motor activity. The MAO-B-inhibitor selegiline, the NMDAR-antagonist memantine and the antioxidants N-acetyl-cysteine (NAC) and melatonin were tested as potential pharmaceuticals. For the first time ever, the present study shows a disruption of protein expression of the glutamatergic transporters EAAT1 and EAAT2 in the putamen during an SIV infection, and a dramatic loss of EAATs associated with the development of AIDS. In the nucleus accumbens, a relatively constant protein expression of EAAT1 and EAAT2 was found during the progression of the SIV infection. Additionally it has been proved that TNF-alpha gene expression in the putamen and TNF-alpha protein expression in the nucleus accumbens increase in the course of an SIV infection. It was replicated that selegiline is unsuitable as a neuroprotective agent regarding SIV encephalitis. Memantine, NAC and melatonin, on the other hand, largely improved the expression of EAAT1 and EAAT2, and stimulated the immune system, so that these substances can be taken into consideration as possible neuroprotective pharmaceuticals. In both brain regions, the Indian macaques showed a higher TNF-alpha expression level than the Chinese macaques. This finding corresponds to the fact that the course of an SIV infection is faster and more severe in Indian macaques.

Fine temporal regulation of dopamine transmission is critical to its effects on behaviour. Dopamine can be cleared from the synapse either by recycling via the dopamine transporter (DAT) or by enzymatic degradation involving catechol-O-methyltransferase (COMT). DAT recycling predominates in striatum and contributes to dopaminergic regulation of reward-guided behaviour, while COMT degradation predominates in cortex and modulates executive functions. However, human functional imaging studies demonstrate interactive effects of DAT and COMT genotype, suggesting that the traditional division between DAT and COMT is not so clear-cut. Given the interdependence of mesolimbic and mesocortical circuitry and the presence of COMT in the striatum, it is possible that DAT and COMT interact to a greater extent than previously thought. We investigated the contributions of DAT and COMT to regulation of dopamine transmission and reward-guided behaviour by combining in vivo electrochemical recording, pharmacology, and behavioural testing in mice. Using fast scan cyclic voltammetry to record evoked dopamine release in anaesthetised animals, we found that systemic DAT blockade increased the size of dopamine transients in the nucleus accumbens (NAc) but not in the medial frontal cortex (MFC), demonstrating that DAT regulates phasic striatal dopamine release and confirming that DAT makes little contribution to regulation of cortical dopamine transmission. Unexpectedly, COMT inhibition did not affect evoked dopamine transients in either the NAc or the MFC. In agreement with these findings, systemic administration of a DAT blocker, but not of a COMT inhibitor, increased motivation to work for reward in a progressive ratio paradigm. COMT inhibition also had little effect on reinforcement learning (RL) strategies during reward-guided decision making. Intriguingly, however, we found that DAT blockade both decreased the influence of model-free RL and increased the influence of model-based RL on behaviour. Our study confirms that DAT regulates dopamine transmission in striatum but not in cortex and indicates that sub-second changes in dopamine transmission in both regions are largely insensitive to COMT. However, our behavioural data reveal the importance of striatal dopamine in multiple components of reward-guided behaviour, including both motivational aspects traditionally associated with striatum as well as cognitive aspects heretofore mainly associated with cortical function. Together, these findings emphasise that reward processing occurs across corticostriatal circuits and contribute to our understanding of how striatal dopamine transmission regulates reward-guided behaviours.

The ability to take effective decisions is fundamental for successful environmental adaptation and survival. In this thesis, I investigated situations in which decisions appear irrational, at least from certain standpoints. I conducted a behavioural decision-making experiment in two groups of macaques: controls and a group with ventromedial prefrontal cortex/medial orbitofrontal cortex (vmPFC/ mOFC) lesions. Some choices lead to compound outcomes composed of different constituent parts. Control macaques' decisions suggested their estimates of the value of the compound were biased away from the sum of the values of the constituents and towards their mean. Lesions of vmPFC/mOFC diminished the size of the effect so that macaques in some ways appeared to make more rational decisions. Based on the results of this experiment I devised a similar Functional Magnetic Resonance Imaging (fMRI) paradigm with the control animals. This demonstrated strong vmPFC/mOFC activity when similar decisions were made and suggested a value comparison process. In addition, I investigated the role of dopamine in learning using Fast-Scan Cyclic Voltammetry (FSCV), while rats performed a simple decision-making task. Theories about the role of dopamine in learning have focused on the possibility that it codes scalar reward value prediction errors. Less consideration has been given to the possibility that dopamine might reflect prediction errors about reward identities regardless of value. I measured dopamine in the nucleus accumbens when unexpected changes in reward value or identity occurred while rats executed a two-choice two-reward instrumental task. Dopamine levels in the nucleus accumbens reflected reward value prediction errors. In addition, however, they also reflected some information about reward identity under some circumstances. Further investigation suggested that this might be due to differences in the nutritional value of different reward types that did not have clear measurable impacts of behaviour in the tasks that I used.

The current study analyzed the effects of environmental enrichment versus isolation housing on the behavioral sensitization to nicotine in the neonatal quinpirole (NQ; dopamine D2-like agonist) model of dopamine D2 receptor supersensitivity, a rodent model of schizophrenia. NQ treatment in rats increases dopamine D2 receptor sensitivity throughout the animal's lifetime, consistent with schizophrenia. Animals were administered NQ (1 mg/kg) or saline (NS) from postnatal day (P)1 to P21, weaned, and immediately placed into enriched housing or isolated in wire cages throughout the experiment. Rats were behaviorally sensitized to nicotine (0.5 mg/kg base) or saline every consecutive day from P38 to P45, and brain tissue was harvested at P46. Results revealed that neither housing condition reduced nicotine sensitization in NQ rats, whereas enrichment reduced sensitization to nicotine in NS-treated animals. The nucleus accumbens (NAcc) was analyzed for glial cell line-derived neurotrophic factor (GDNF), a neurotrophin important in dopamine plasticity. Results were complex, and revealed that NAcc GDNF was increased in animals given nicotine, regardless of housing condition. Further, enrichment increased GDNF in NQ rats regardless of adolescent drug treatment and in NS-treated rats given nicotine, but did not increase GDNF in NS-treated controls compared to the isolated housing condition. This study demonstrates that environmental experience has a prominent impact on the behavioral and the neural plasticity NAcc response to nicotine in adolescence.

Cocaine use disorder is a significant health problem, negatively impacting individuals afflicted. While preclinical self-administration research has provided invaluable insight into the neurobehavioral mechanisms that underlie cocaine abuse, cocaine use outside of the laboratory occurs within an environment where other goods are also available ubiquitously. Although there is an ever-increasing literature investigating drug vs. non-drug choice in rodent models and how alternative goods can compete with the subjective value of cocaine, the neurobiological mechanisms that are associated with cocaine preference remains largely unknown. Additionally, current drug vs. non-drug choice studies use procedures that confound preference with intake, such that preference measures are directly reflective of individual experience with drug and non-drug reinforcers earned through the choices that are made; simply, preference and intake are the same. Moreover, differences in cocaine experience can result in differential neural adaptations, thus making it difficult to determine if the neurobiological mechanisms underlying choice are related to preference or drug intake. Herein a novel choice procedure, which controls for reinforcer intake (controlled reinforcer ratio; CRR), was used to explore how certain reinforcer dimensions (i.e., magnitude and frequency) influence cocaine preference. In addition, neuronal activity, measured via c-fos expression, in the orbitofrontal cortex and nucleus accumbens, areas associated with decision-making and valuation, for cocaine and food were independently targeted and labeled using fluorescent in situ hybridization and fluorescent immunohistochemistry. First, unlike prototypical choice procedures where preference and intake are confounded, the CRR choice procedure was able to dissociate the two. Under the CRR choice procedure, it was revealed that both magnitude and frequency, independent dimensions of reinforcement, greatly influence preference for cocaine. Furthermore, the CRR choice procedure was sensitive to manipulations known to influence cocaine preference while keeping reinforcer intake constant. When neuronal activity was examined after CRR training, the number of cocaine activated cells, relative to food activated cells, did not correlate with individual preferences for cocaine despite overall reinforcer intake being held constant. Instead, results suggest neuronal activity for cocaine was related to overall cocaine intake. Overall, these results give impetus for utilizing the CRR choice procedure to better investigate how drug and non-drug reinforcers are afforded differential subjective value and compete for preference. Moreover, use of a CRR choice procedure may lead to identification of specific neurobehavioral mechanisms and lead toward future development of more effective pharmacological and behavioral treatments to ameliorate substance use disorders.

Multiple interactions between dopamine (DA), glutamate, and nitric oxide (NO) in mesolimbic and corticostriatal circuits suggest that NO may play a critical role in cocaine-induced behavioral and neural plasticity. Clinical and preclinical studies have revealed that females and adolescents display unique vulnerabilities to the behavioral and neurochemical effects of cocaine as a result of sex-dependent and ontogeny-dependent differences in dopaminergic systems. Thus, my research objectives were to investigate the contributions of the neuronal nitric oxide synthase (nNOS) gene, ontogeny, and gender on the rewarding and sensitizing effects of cocaine. I found that nNOS significantly influences the rewarding aspects of cocaine in adolescent mice and adult male mice (i.e., major deficits in several phases of cocaine conditioned place preference (CPP) were detected in nNOS knockout (KO) adolescent mice and nNOS KO adult male mice). However, the contribution of nNOS was sex-dependent as CPP phases were normal in KO adult females. In contrast to CPP, I found a major ontogeny-dependent contribution of nNOS to the sensitizing effects of cocaine. Namely, while nNOS is essential for the development of behavioral sensitization in adult males, this type of behavioral plasticity develops independently of nNOS during adolescence. The contribution of nNOS was once again sex-dependent as behavioral sensitization was normal in adult KO females. Together, this line of investigation has revealed that the NO-signaling pathway has a) a sex-dependent role in the neuroplasticity underlying cocaine CPP and b) a sex-dependent and ontogeny-dependent influence on cocaine-induced behavioral sensitization. Stereological and western blot analysis revealed that a sensitizing regimen of cocaine resulted in an increase in nNOS and tyrosine hydroxylase (TH) immunoreactivity in the dorsal striatum (dST) of adult, but not adolescent, wild-type (WT) male mice. In the absence of nNOS, dopaminergic neurons in the ventral tegmental area (VTA) were severely reduced and cocaine caused a downregulation of dST TH suggesting that nitrergic levels modulate TH. Thus, the finding that nNOS is essential for the development of sensitization in adulthood, but not adolescence, together with the fact that cocaine upregulated nNOS and TH in the dST in adult, but not adolescent mice, strongly suggest that the nitrergic system underlies behavioral sensitization through modulation of the dopaminergic system in adulthood. These findings suggest different approaches in the clinical treatment of drug craving and drug-seeking behavior in adolescent and adult patients.

Binge alcohol consumption is a rising concern in the United States, especially among adolescents as during this developmental period alcohol use is usually initiated and has been shown to cause detrimental effects on brain structure and function. These findings have been established through the use of binge models in animals, where animals are repeatedly administered high doses of ethanol typically over a period of three or four days. While such work has examined the effects of a four-day and repeated three-day binge, there has been almost no work conducted aimed at investigating the long-term behavioral and neurochemical and/or functional consequences of repeated binge pattern administration during adolescence relative to adulthood on later ethanol-induced behavior and neurochemistry in adulthood. The present set of experiments aimed to examine the dose-response and age-related differences induced by repeated binge pattern ethanol administration during adolescence or adulthood on voluntary ethanol consumption (Aim 1), changes in ethanol metabolism following ethanol pretreatment (Aim 2) and mesolimbic dopamine functionality (Aim 3) in adulthood. In both experiments, adolescent and adult male rats were intragastrically administered ethanol (0.5, 1.0 or 2.0 g/kg/ig) or isovolumetric water on postnatal days (PND) 28-31, PND 35-38 and PND 42-45 for adolescent rats and PND 60-64, PND 67-70 and PND 74-77 for adult rats. In both experiments all rats underwent fourteen days of abstinence (PND 46-59 or PND 78-91, respectively). Subsequently, in Experiment 1, all rats underwent voluntary ethanol consumption procedures, in which animals were exposed to 10% ethanol combined with decreasing saccharin concentrations across days from PND 60-82 for adolescent-exposed rats and PND 92-114 for adult-exposed rats. Finally, on PND 83 and PND 115, respectively, all animals were challenged with 2.0 g/kg ethanol and trunk blood samples were collected at 60 and 240 minutes post-injection. Results indicate there was a significant increase in voluntary ethanol intake in adolescent ethanol-exposed rats pretreated with 2.0 g/kg relative to their adult ethanol-pretreated counterparts. Faster ethanol metabolism was observed in adolescent rats pretreated with 2.0 g/kg during adolescence relative to adolescent-exposed rats pretreated with 0.5 g/kg and adults pretreated with 2.0 g/kg. For Experiment 2, all rats underwent surgery (PND 60 for adolescent-exposed and PND 92 for adult-exposed rats). From PND 61-64 for adolescent-exposed and PND 93-96 for adult exposed rats, all animals underwent recovery from surgery. Finally, all rats underwent in vivo microdialysis on PND 65 for adolescent-exposed and PND 97 for adult-exposed rats, with K+ (100 mM) infused into the ventral tegmental area and accumbal dopamine overflow assessed in the nucleus accumbens septi. The results from Experiment 2 indicate lasting changes in mesolimbic dopamine functionality with a trend for decreased potassium-stimulated dopamine overflow in the nucleus accumbens septi in adolescent-ethanol pretreated rats and a trend for increased potassium-stimulated dopamine overflow in adult ethanol-pretreated rats. The results from the present set of experiments show the dose-dependent impact of binge-pattern ethanol exposure during adolescence on subsequent ethanol consumption and ethanol metabolism in adulthood. These findings indeed determine adolescence as a period of vulnerability to the long-term changes in ethanol consumption relative to similarly-exposed adult male rats. Importantly, the results of Experiment 2 indicate an alteration in the functionality of the mesolimbic pathway in adulthood following adolescent binge pattern ethanol exposure, which demonstrates a long-term depression in mesolimbic dopamine functionality following adolescent binge pattern ethanol exposure.

Not available